4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-052221
EVP, Research & CSO acquired 3,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-24 | Exercise or conversion : show line 1 in the form | +3,700 | $1.53 | $5,661 | 23,700 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-24 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −3,700 | 463,385 | D |
Loading xslF345X03/doc4.xml…